The immune response to Epstein-Barr virus

被引：39

作者：

Callan, MFC ^{[1
]}

机构：

[1] Univ London Imperial Coll Sci Technol & Med, Dept Immunol, London W12 0NN, England

来源：

MICROBES AND INFECTION | 2004年 / 6卷 / 10期

基金：

英国医学研究理事会;

关键词：

herpesvirus; 4; human; CD8-positive T-lymphocytes; CD4-positive T-lymphocytes;

D O I：

10.1016/j.micinf.2004.04.014

中图分类号：

R392 [医学免疫学]; Q939.91 [免疫学];

学科分类号：

100102 ;

摘要：

Epstein-Barr virus is a gammaherpes vir-us that establishes persistent infection in the majority of humans. Despite the potent oncogenic potential of the virus it is relatively rarely associated with malignant disease. This review focuses on the cellular immune responses that successfully control Epstein-Barr virus infection in most individuals. (C) 2004 Elsevier SAS. All rights reserved.

引用

页码：937 / 945

页数：9

共 31 条

[21] Human CD4+ T lymphocytes consistently respond to the latent Epstein-Barr virus nuclear antigen EBNA1 [J].

Münz, C ;

Bickham, KL ;

Subklewe, M ;

Tsang, ML ;

Chahroudi, A ;

Kurilla, MG ;

Zhang, D ;

O'Donnell, M ;

Steinman, RM .

JOURNAL OF EXPERIMENTAL MEDICINE, 2000, 191 (10) :1649-1660

[22] Epstein-Barr nuclear antigen 1-specific CD4+ Th1 cells kill Burkitt's lymphoma cells [J].

Paludan, C ;

Bickham, K ;

Nikiforow, S ;

Tsang, ML ;

Goodman, K ;

Hanekom, WA ;

Fonteneau, JF ;

Stevanovic, S ;

Münz, C .

JOURNAL OF IMMUNOLOGY, 2002, 169 (03) :1593-1603

[23] X-linked lymphoproliferative disease: 2B4 molecules displaying inhibitory rather than activating function are responsible for the inability of natural killer cells to kill Epstein-Barr virus-infected cells [J].

Parolini, S ;

Bottino, C ;

Falco, M ;

Augugliaro, R ;

Giliani, S ;

Franceschini, R ;

Ochs, HD ;

Wolf, H ;

Bonnefoy, JY ;

Biassoni, R ;

Moretta, L ;

Notarangelo, LD ;

Moretta, A .

JOURNAL OF EXPERIMENTAL MEDICINE, 2000, 192 (03) :337-346

[24] Differential kinetics and specificity of EBV-specific CD4+ and CD8+ T cells during primary infection [J].

Precopio, ML ;

Sullivan, JL ;

Willard, C ;

Somasundaran, M ;

Luzuriaga, K .

JOURNAL OF IMMUNOLOGY, 2003, 170 (05) :2590-2598

[25] Development of Epstein-Barr virus-specific memory T cell receptor clonotypes in acute infectious mononucleosis [J].

Silins, SL ;

Cross, SM ;

Elliott, SL ;

Pye, SJ ;

Burrows, SR ;

Burrows, JM ;

Moss, DJ ;

Argaet, VP ;

Misko, IS .

JOURNAL OF EXPERIMENTAL MEDICINE, 1996, 184 (05) :1815-1824

[26] Asymptomatic primary Epstein-Barr virus infection occurs in the absence of blood T-cell repertoire perturbations despite high levels of systemic viral load [J].

Silins, SL ;

Sherritt, MA ;

Silleri, JM ;

Cross, SM ;

Elliott, SL ;

Bharadwaj, M ;

Le, TTT ;

Morrison, LE ;

Khanna, R ;

Moss, DJ ;

Suhrbier, A ;

Misko, LS .

BLOOD, 2001, 98 (13) :3739-3744

[27] Integration of apoptosis and telomere erosion in virus-specific CD8+ T cells from blood and tonsils during primary infection [J].

Soares, MVD ;

Plunkett, FJ ;

Verbeke, CS ;

Cook, JE ;

Faint, JM ;

Belaramani, LL ;

Fletcher, JM ;

Hammerschmitt, N ;

Rustin, M ;

Bergler, W ;

Beverley, PCL ;

Salmon, M ;

Akbar, AN .

BLOOD, 2004, 103 (01) :162-167

[28] Type 2 cytokines predominate in the human CD4+T-lymphocyte response to Epstein-Barr virus nuclear antigen 1 [J].

Steigerwald-Mullen, P ;

Kurilla, MG ;

Braciale, TJ .

JOURNAL OF VIROLOGY, 2000, 74 (15) :6748-6759

[29] Epitope focusing in the primary cytotoxic T cell response to Epstein-Barr virus and its relationship to T cell memory [J].

Steven, NM ;

Leese, AM ;

Annels, NE ;

Lee, SP ;

Rickinson, AB .

JOURNAL OF EXPERIMENTAL MEDICINE, 1996, 184 (05) :1801-1813

[30]

Tan LC, 1999, J IMMUNOL, V162, P1827

← 1 2 3 4 →